Commutee

Bristol-Myers bulks up with $74 billion deal to buy Celgene

January 3, 2019 by  
Filed under News

Bristol-Myers Squibb Co said on Thursday it would buy Celgene Corp for about $74 billion, creating one of the biggest pharmaceutical companies and combining two significant cancer drug businesses.


Source: Reuters Business News

Comments are closed.